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Feline immunodeficiency virus infection of cats provides a model to elucidate mechanisms of lentiviral pathogenesis. We isolated a non-
domestic FIV from a Pallas’ cat, FIV-Oma, which replicates in feline PBMCs and CRFK cells. To gain insights into FIV pathogenesis, we
compared rates of viral replication and apoptosis of FIV-Oma with FIV-PPR in the MYA-1 T-cell line. To minimize heterogeneity of virus,
infections were initiated with virus derived from molecular clones. Viral DNA and RNA levels, assessed by qPCR and qRT-PCR, apoptosis,
and supernatant reverse transcriptase were slower in FIV-Oma infections. Immunostaining for cellular Gag showed that few cells were
productively infected. The majority of cells infected with either virus instead became apoptotic. Apoptosis was detectable within 6 h PI,
suggesting activation of a signaling pathway. We propose that apoptosis is due to interaction of virus with cells, and is the usual outcome of
infection by cytopathic FIVs in these cells.
D 2004 Elsevier Inc. All rights reserved.
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Feline immunodeficiency virus (FIV) infection of cats
(Bendinelli et al., 1995; Pedersen, 1990) results in a similar
chronic course of T-cell depletion as does HIV infection of
humans. FIV infection of domestic cats has been promoted
as a model to elucidate mechanisms of lentiviral patho-
genesis, as well as a model system for antiviral therapy and
vaccination protection (Yamamoto et al., 1993). In non-
domestic felids, lentiviruses similar to domestic cat FIV
(FIV-Fca), both by homology and genetic organization, have
been described in four other species (Troyer et al., 2004).
All of these related feline immunodeficiency viruses have
fewer accessory genes than HIV (Lamont et al., 1991;
Phillips et al., 1990b; Talbott et al., 1989). Although it is
clear that FIV infection of domestic cats induces an
immunodeficiency, there is no consensus that infection by0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.11.042
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E-mail address: jwc3@cornell.edu (J.W. Casey).the related viruses of non-domestic felids results in clinical
disease (Biek et al., 2003; Carpenter and O’Brien, 1995;
Olmsted et al., 1992) and are presumed to be in balance with
their hosts.
This laboratory had previously isolated an FIV from a
Pallas’ cat (Otocolubus manul), FIV-Oma (Barr et al., 1995,
1997), which was found to replicate in domestic cat
PBMCs, and in a feline kidney cell line, CrFK. An
infectious clone of FIV-Oma has been constructed (Long,
1997). We have been using that clone for experiments
relating to mutagenesis of accessory genes and to attempt to
define their functions. We were also interested in inves-
tigating particular pathogenic features of both FIV-Oma and
its molecular clone pOma-3, in that they exhibited
cytopathic effects in CrFK cells. Both isolate and clone
virus stocks rapidly killed (~14 days) CrFK cultures, and we
had noted that part of that killing was by apoptosis.
Apoptosis in feline T-cell lines (Johnson et al., 1996) and
in feline PBMCs (Holznagel et al., 1998) has been observed
with FIV infection. The exact relationship between infection05) 519–528
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compare the cytopathic effects of a domestic cat FIV with
FIV-Oma in T-cells under the ex vivo environment of cell
culture. We used an established feline T-cell line (MYA-1)
(Miyazawa et al., 1992) in order to contrast and describe the
responses to a trans-genus lentiviral infection vs. natural
host-species infection. To minimize variation due to viral
quasispecies, these experiments were initiated with early-
passage virus from cells transfected with infectious mole-
cular clones. These virus stocks are designated with the
prefix bpQ.Results
pOma3 and pPPR have different tropisms in several
domestic feline cell types and lines
The ability of a virus isolate or virus produced from an
infectious clone to propagate in a particular cell line was
assayed by measuring supernatant reverse transcriptase (RT)
activity. Cell lines used were of lymphoid origin with the
exception of CrFK cells, which are derived from feline
kidney tissue and are anchorage-dependent. Results are
summarized in Table 1. All isolates and virus from
molecular clones replicated in domestic cat PBMCs. pPPR
(Phillips et al., 1990a) grew only in the MYA-1 and FeT-1C
cell lines which are both IL-2 dependent, whereas FIV-Oma
and pOma3 also grew in 3201 cells and CrFK cells, which
are IL-2 independent. FIV-Oma was initially cytopathic in
3201 cells, but eventually a cell population recovered and
the culture supernatant continued to display high levels of
RT activity even after several complete media changes,
indicating a chronic productive infection (data not shown).
Only pFIV-14, a virus stock from an FIV-Petaluma
molecular clone derived from CrFK-adapted virus (a classic
bCrFK tropicQ virus) (Olmsted et al., 1989) productively
infected FeT-J cells. Both pPPR and pOma3 replicated in
MYA-1 cells as evidenced by increased RT activity with
time in culture. Nearly all cells in the pPPR-infected culture
were non-viable by day 14, indicating cytopathicity. The
culture infected with pOma3 was non-viable by day 21. InTable 1
Tropism of virus stocks
pFIV-14 pPPR FIV-Oma pOma3
PBMC* + + +SI +
CrFK +  +SI +SI
3201 ND  + +
FeT-1C* ND + + +
FeT-J ND  + +
MYA-1* ND +SI + +
Stocks of pFIV-14, pPPR, pOma3, and FIV-Oma were tested for their
ability to replicate in feline cells and cell lines. (*) denotes IL-2 dependent
lines, (+) indicates replication as measured by supernatant RT activity, ()
indicates no replication, ND means not done, SI indicates that the virus
caused syncytia.summary, the MYA-1 feline T-cell line appeared to be an
appropriate ex vivo host for both pPPR and pOma3.
Also as indicated in Table 1, virus isolates and molecular
clones differed in their abilities to induce syncytia, another
infection-related cytopathic effect. pPPR infection caused
syncytia in MYA-1 cultures; pOma3 (and the parental
isolate, FIV-Oma) induced syncytia in CrFK cells, but no
syncytia were observed in any of the T-cell lines, although
FIV-Oma infection caused small syncytia in domestic cat
PBMCs (Barr et al., 1995). We had previously observed
that, after infection of CrFK cells with either FIV- Oma or
transfection-derived virus stock from pOma3, another
cytopathic sequela of infection was detachment of single
cells. These floating cells were found to be apoptotic (CAS,
personal communication).
To compare and contrast the cell-culture consequences of
MYA-1 infection with the domestic FIV infectious clone
and the trans-species pOma3, we set up multiple cultures of
MYA-1 and infected them with 3-log dilutions of expanded
pPPR and pOma3 (MYA-1 culture-derived) virus super-
nates. Cultures were then monitored daily, or at other
intervals post-infection (PI), for various metrics of FIV
replication: proviral DNA synthesis, supernatant viral RNA
and RT activity, production of GAG (within cells), and
apoptosis. These events were monitored during a single
experiment.
Kinetics of pOma3 replication and cytopathology
MYA-1 cultures were infected with three log doses of
pOma3 supernates. Appearance of pOma3 viral DNA was
monitored daily by quantitative PCR (qPCR) (Fig. 1A).
Minimum reproducible sensitivity of viral DNA detection
was twenty copies per 100 ng DNA, or 120 copies per 105
cells, assuming 6 pg DNA per cell. Viral DNA synthesis
was first detectable on day 5 PI with log2, day 6 PI with
log1, and day 8 PI with log0. Subsequently, all three
cultures had increasing viral DNA loads: log2 loads were
maximal at twenty-six copies per cell on day 8, log1 culture
had thirty-two copies per cell on day 10, then thirty-six
copies per cell at day 15 PI after a complete medium change
on day 12. We presume that the apparent decrease in
provirus at medium changes was due to loss of infected cells
during centrifugation. Log0 maximal viral DNA load was
thirteen copies per cell on day 13. Thus, early kinetics of
viral DNA synthesis is positively correlated with increasing
virus input. The state of viral DNA (integrated or
unintegrated) was not determined. Decreasing viral DNA
loads were observed after day 15 for all cultures. The
experiment was terminated on day 21, when most of the
cells were nonviable.
Quantitative RT-PCR was performed on supernatant
RNA samples from day 1 to day 10 PI (Fig. 1B). Day 1–
2 levels were attributed to virus added to initiate infection.
Sensitivity of qRT-PCR was 200 copies/reaction, corres-
ponding to approximately 1.7  104 copies per mL.
Fig. 1. Parameters of viral replication and apoptosis in cultures. A–D, pOma3 stock infections. E–H, pPPR stock infections. For all graphs, log2 = purple,
log1 = green, log0 = orange, control = blue. A and E: viral DNA loads per cell, measured as described in Materials and methods. Panels B and F:
supernatant RNA copies/mL. Panels C and G: supernatant RT activity. Panels D and H: apoptosis, measured by flow cytometry.
C.A. Sutton et al. / Virology 332 (2005) 519–528 521
Table 2
Microscopic field counts of infected/apoptotic cells PI
FIV
clone
Day
PI
Total
cells
Gag(+) Percent
infected
Apoptotic Percent
apoptotic
PPR
Log0
3 371 8 2.1 61 16.4
PPR
Log1
3 266 11 4.1 55 20.7
PPR
Log2
3 198 23 11.6 41 20.7
Oma3
Log0
6 512 16 3.1 36 7.0
Oma3
Log1
6 296 13 4.4 42 14.2
Oma3
Log2
6 336 29 8.7 67 19.9
Oma3
Log0
7 365 15 4.1 37 10.4
Oma3
Log1
7 287 16 5.6 48 16.7
Oma3
Log2
7 126 10 7.9 29 23.0
Cells at times noted PI were stained with Hoechst 33342/propidium iodide
to detect apoptosis and cellular Gag expression as described in Materials
and methods.
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(log1), and days 5–6 (log0), and increased thereafter, with
a positive correlation between input dose and time of
appearance of viral RNA.
Supernatant RT activity was monitored from daily
samples throughout the course of infection. In agreement
with supernatant qRT-PCR results, RT increased in relation
to log dose, peaking at day 9 (log2), day 10 (log1), and day
11 (log0), and then declining. Peak RT values were similar
for all three inocula (Fig. 1C).
Apoptosis was measured by FACS analysis (Fig. 1D).
Although background apoptosis was evident in the mock-
infected control culture over the course of the experiment,
apoptosis was more pronounced with pOma3 infection, as
early as day 2 PI. Subsequently, apoptosis increased
throughout, in a dose-dependent manner, with maximally
75–85% of the cells becoming apoptotic. We are unaware of
the half-life of cells once apoptosis has begun. Comparison
of percent apoptotic cells (Fig. 1D) with peak RT values
(Fig. 1C) shows that on day 9, 40% of log2 cells were
apoptotic; day 10, 38% of log1 cells were apoptotic; day 11
PI, 38% of log0 cells were apoptotic.
Kinetics of pPPR replication and cytopathology
After initiating infection of MYA-1 cells with three log
doses of pPPR virus stock, early viral replication was
monitored daily by qPCR. Viral DNA synthesis was
detected at day 2 PI at log2, and at day 4 for log1 and
log0 doses. Panel E of Fig. 1 shows the kinetics of
appearance of proviral DNA, which has been normalized
to cell number. Minimum detectable viral DNA loads were
ten copies per 100 ng of cellular DNA, corresponding to
sixty proviruses per 105 cells. Viral DNA levels increased
rapidly after first detection, in an inverse order to virus dose:
log2 levels remained low (1.3 copies or less per cell) while
log0 levels approached forty-five copies per cell on day 8.
With increasing culture time, all viral DNA loads decreased,
in a manner similar to that seen with pOma3 infections in
Fig. 1A. Appearance of viral DNAwas earlier than that seen
with pOma3 at all log doses.
Appearance of supernatant virus was monitored for days
1–10 PI by quantitative RT-PCR (Fig. 1F). Day-1 levels
were again attributed to residual virus added to initiate
infection. Sensitivity of detection was 100 copies per
reaction, or approximately 8.5  103 copies per mL of
supernate. Viral RNA was detected in cell culture super-
natants on day 5 (log0), day 4 (log1), and day 3 (log2). Peak
RT activity was measured on day 6 (log2), days 7–9 (log1),
and day 9 (log0).
Cell-free virus was monitored by supernatant RT
activity, shown in Fig. 1G. Early appearance was dose-
dependent; RT activity was detectable by day 4 (log2), day
5 (log1), and day 6 (log0). There is a discrepancy in RNA
vs. RT with regards to the log dose: log2 culture had the
highest supernatant RNA loads (Fig. 1F) but the lowest RTactivity (Fig. 1G), and the lowest proviral copy number per
cell (Fig. 1E).
Apoptosis in pPPR-infected cultures is shown in Fig. 1H.
Again, apoptosis increased throughout the experiment, with
early levels proportional to virus dose. The percentage of
apoptotic cells was equivalent for all log doses by day 9 PI,
and averaged about 70% at the end of the experiment.
Comparison of percent apoptotic vs. peak RT activity
showed that for log2 at day 6 PI, 24% were apoptotic; for
log1 day 7, 22% were apoptotic; for log0, day 9, 28% were
apoptotic.
Apoptosis occurs prior to productive infection
Having observed that an increasing percentage of the
cells in both pPPR and pOma3 infections were apoptotic
and presumably no longer producing virus, we looked at
cellular Gag production as a measure of late viral protein
synthesis, and as a minimal estimate of the number of
productively infected cells. We measured expression of Gag
using mouse–anti-FIV-p24 IgG, a monoclonal antibody
developed for domestic cat FIV-P24. This monoclonal
antibody also recognizes FIV-Oma Gag by Western blot
and by IFA. Cell samples from days 1 to 7 PI were stained
with Hoechst 33342, propidium iodide (to identify apoptotic
vs. necrotic cells), and the anti-Gag antibody. No production
of Gag was observed on Day 1 in any of the cultures. By
day 3, expression of Gag was observed in pPPR-infected
cells at all inoculum levels. By day 3, Gag expression was
observed in cultures infected with pOma3 at log2 and log0
(but not log1). By day 7 PI, all pOma3 cultures had Gag (+)
cells. Table 2 shows a compilation of microscopic field-
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from pOma3-infected cultures on days 6 and 7 PI.
Interestingly, we saw no evidence of Gag(+) cells that were
also apoptotic. Several details are worth noting: one is the
low percentage of bproductively infectedQ cells at these time
points. Secondly, the percent apoptotic cells measured by
field counts in close agreement with the percentages
measured by FACS (Figs. 1D and H). Lastly, by day 15
PI in both pPPR- and pOma3-infected cultures, greater than
half of the cells were apoptotic and probably not targets for
new infection.
Apoptosis is detectable early (6 h) after virus addition
MYA-1 cells were infected with either pOma3 or pPPR
supernates produced from CrFK cultures. Cells were
sampled at 6 h PI and stained with Hoechst 33342,
propidium iodide, and Annexin V-FITC. Early apoptotic
cells stain with Annexin V-FITC (green) in the absence of
propidium iodide (red). Cells that stained with propidium
iodide, but not with Annexin V-FITC and did not have
fragmented nuclei or condensed chromatin, were classified
as necrotic. Few apoptotic cells were detected in the control.
Increased apoptosis was seen in cells infected with pPPR.
Cells infected with pOma3 showed increased apoptosis
relative to control, but the level of apoptosis in Oma3-
infected cells was less than that seen in pPPR-infected cells
(Fig. 2). These data are in agreement with our earlier results
that demonstrated that pOma3 infection was consistently
slower than pPPR infection.Discussion
Cell tropism of different virus strains affects pathology
and viral dissemination in host tissue (Pancino et al., 1995).
In vivo, domestic cat FIVs infect macrophages (Vahlenkamp
et al., 1999), B lymphocytes, CD4+ and CD8+ T lympho-
cytes (English et al., 1993; Pedersen et al., 1989), and CNS
tissue (Dow et al., 1992), with some isolates being more
tropic to one tissue type than to others. FIV isolates displayFig. 2. Apoptosis is detected by 6 h PI. MYA-1 cells were infected with either pOm
at 6 h PI and stained with Hoechst 33342, propidium iodide, and Annexin V-FITC
propidium iodide (red). Cells that stained with propidium iodide but not with An
were necrotic.different cell-line tropisms ex vivo as well (Dean et al.,
1999). Our initial purpose was to compare cellular tropisms
of virus produced from two infectious clones: pOma3,
derived from a non-domestic cat FIV, and pPPR, derived
from a San Diego FIV isolate (Phillips et al., 1990a). We
observed that pPPR infects only cells of lymphoid origin
that are IL-2 dependent, whereas pOma3 can infect some
IL-2-independent cells as well as CrFK, which are of non-
lymphoid origin. pPPR tropism results were in agreement
with those of Lerner et al. (1998), Dean et al. (1999), and
Hosie et al. (2002).
Laboratory-adapted strains of FIV (which have expanded
cell tropism ex vivo including CrFK cells) have been shown
to require the CXCR4 chemokine receptor for cell binding
and entry (de Parseval and Elder, 2001; Hosie et al., 1998;
Poeschla and Looney, 1998). Recently, Shimojima et al.
(2004) demonstrated that domestic cat FIV isolates use
CD134 as the primary receptor for cell entry and CXCR4
was required as a co-receptor. They also confirmed that
reporter virus pseudotyped with pPPR ENV had increased
infectivity in cells expressing CD134, suggesting that pPPR
is also using this T-cell activation marker as its primary
receptor. We hypothesize that pOma3 is likely to interact
with CXCR4, similar to tissue-culture adapted domestic
FIVs. It is not clear if such CrFK-tropic virus, like pFIV-14,
interacts exclusively with CXCR4, or with other receptors
on lymphoid cells.
Our purpose in the later experiments was to examine the
kinetics of virus replication and the cellular responses to
infection. We used quantitative PCR and RT-PCR to follow
appearance of viral DNA and supernatant RNA after
infection. Those measurements give absolute numbers of
molecules, which we normalized to cell number and
volume of supernatant, respectively. Supernatant reverse
transcriptase activity was monitored by an enzymatic assay.
Apoptosis was detected by flow cytometry, giving percen-
tages of cells that stained with Annexin V. Productive
infection was defined by immunostaining cells with anti-
Gag, also expressed as a percentage of the cell population.
To compare results with these different assays, we have
made several assumptions. First, we assume that super-a3 or pPPR supernates from transfections of CrFK cells. Cells were sampled
. Early apoptotic cells stain with Annexin V-FITC (green) in the absence of
nexin V-FITC and did not have fragmented nuclei or condensed chromatin
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both reflect viral particles. Second, we assume that viral
DNA represents the product of an infectious virion, but we
cannot deduce its state in the cell (integrated, unintegrated,
linear, or circular). We are also unable to determine
whether, for example, 20 copies of viral DNA per cell
equates to 100 percent of cells having on average 20
potential proviruses or 10% of the cells containing 200.
Next, we assume that Gag positivity represents the sum of
virus entry, proviral integration, and subsequent release of
progeny.
Particular aspects of the replication of these two viruses
are notable. Examination of the early kinetics of appearance
of viral DNA and supernatant RNA and RT positively
correlates with dose of either virus. Second, as stated above,
pOma3 replication, as measured by any parameter, is slower
that that of pPPR. Third, at the highest virus input for pPPR,
viral DNA loads were the least (by over an order of
magnitude), but supernatant RNA levels were the highest.
The high viral DNA copy numbers seen in all other
infections (Figs. 1A and E) are likely due in part to
unintegrated viral cDNA, especially given the low percent-
age of productively infected cells shown in Table 2. This is
consistent with quantitative viral cDNA loads seen in vitro
in cells infected with HIV-1 (Butler et al., 2002). We
detected low total viral DNA levels in the log2 pPPR
infection (1–2 copies per cell, Fig. 1E) at day 3 when
approximately 10% of the culture was Gag(+) (Table 2). As
the dose of PPR inoculum decreased, the total viral DNA
load increased (Fig. 1E). All pOma3 infections showed high
viral DNA loads (averages greater than 10 to 20 copies per
cell) (Fig. 1A), with viral DNA loads increasing with dose.
We hypothesize that the higher doses of pPPR virus resulted
in an increase in provirus formation that subsequently
induce receptor downregulation (perhaps CD134) thus
preventing superinfection, and that pOma3 virus, at least
at the inocula used, does not downregulate a receptor. Since
only integrated viral DNA is transcribed, the log2 pPPR
infection would be predicted to yield higher levels of viral
RNA.
Another comparison of interest is that qRT-PCR results
vs. RT results shown in Fig. 1 suggest that there is 6-fold
less viral RNA in the pOma3 supernates than in pPPR
supernates at the same RT level. Whether this indicates a
packaging defect or higher intrinsic reverse-transcriptase
activity in pOma3 virions is not known.
A comparison of the Env sequences of pPPR and
pOma3 (Fig. 3) shows that these two proteins are quite
divergent, having 23% amino acid identity and 39%
similarity (by charge). In fact, the two orfs are most
homologous over the leader region, which is the first exon
of rev (Phillips et al., 1992), corresponding to amino acids
1–200. Within SU and TM p PPR and pOma3 are only 21%
identical, 37% similar. Interestingly, an SIV isolate from a
l’hoestmonkey (Cercopithecus l’hoesti) (Hirsch et al.,
1999) was found to infect both human and macaquePBMCs ex vivo and macaques in vivo. Such wide tropism
is atypical for most SIVs. The Env sequence of this SIV is
also quite divergent from Envs of other SIVs: a BLAST
comparison of SIVlhoest and SIVcpz envelope shows 30%
identity and 44% similarity. Given the relative sequence
dissimilarity of these two FIV Envs, chimeric versions
might be useful in mapping various determinants of their
different ex vivo tropisms.
Calculation of the number of added virions (from qRT-
PCR data) vs. the log doses of RT activity used to initiate
infection (not shown) indicates that very few of the particles
were infectious, and/or that very few of the cells were
competent for productive infection by either FIV stock. At
log2 doses, greater than 106 pPPR virions per cell were
added. Interestingly, Shimojima et al. (2004) also showed
that in MYA-1 cultures, only a fraction of the cells express
CD134 (17%), and that FIV infection reduced that
percentage to 4% in 2 days. Thus, at least for pPPR
infection, there is compelling evidence that only a small
number of cells are competent for viral entry, and that that
number decreases with time PI, possibly due to virally
induced downregulation of CD134 expression, as discussed
above. As well, in studies of HIV infection of tissue culture
cells, estimates of the ratio of infectious to noninfectious
virions range from one in 3000 to one in 60,000 (O’Doherty
et al., 2000). Thus, there is precedent for low infectivity of
lentiviruses.
Regardless of viral stock, we observed that, with time PI
an increasing percentage of the cells became apoptotic. For
both sets of infections, parameters of productive viral
replication (provirus formation, supernatant RNA and
supernatant RT activity) rose and fell, presumably due in
part to fewer live, uninfected cells as potential targets. As
well, there must have been death of productively infected
cells. We do not know whether their demise was by lysis,
necrosis, or apoptosis.
Inspection of panels D and H of Fig. 1 shows that, at
least for log2 doses of either virus, apoptosis was increased
relative to the control within 2 days PI, before there had
been detectable viral replication. This was confirmed by the
experiment presented in Fig. 2, in which apoptotic cells
could be microscopically visualized as early as 6 h PI. One
could argue that viral stocks contained apoptosis-promoting
substances such as TNFa, which cause this cell death.
However, Linenberger and Deng (1999) also noted rapid
cell death in MYA-1 cultures infected with several FIV
isolates. They explored changes in cytokine transcript
levels following infection and found no induction of either
pro- or anti-apoptotic factors. We propose that apoptotic
MYA-1 cells result from direct interactions of cell and
virion, either at the level of virus binding or entry/fusion,
well before viral gene expression or viral egress. We
hypothesize that these cells are not bbystanders,Q but are
responding to signals from virus (or viral protein)
interactions at the cell surface. There may be different
cell-virus contacts that lead to apoptosis vs. productive
Fig. 3. Alignment of pPPR and pOma3 env sequences done using BLASTp. http://www.ncbi.nlm.nih.gov/blast/bl2seq/bl2.html.
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receptor/co-receptor densities on cells, or differences in
virion structure.Materials and methods
Cell lines and viral stocks
CrFK cells were grown in 70% MEM-H, 30% L-15, and
10% FBS supplemented with 25 mM HEPES, 50 Ag/mL
gentamicin. MYA-1 and FeT-1c cell lines were obtained
from ATCC. Both cell lines were maintained in RPMI 1640
with 2 mM l-glutamine, adjusted to contain 1.5 g/L sodium
bicarbonate, 4.5 g/L glucose, 1.0 mM sodium pyruvate, and
supplemented with 10 mM HEPES, 0.05 mM 2-mercapto-
ethanol, 50 Ag/mL gentamicin, 100 units/mL human
recombinant IL-2 (Peprotech), and 10% heat inactivated
fetal bovine serum (Omega Scientific), according to ATCCinstructions. FeT-J cells were also obtained from ATCC and
were grown in RPMI 1640 with 2 mM l-glutamine,
adjusted to contain 1.5 g/L sodium bicarbonate and
supplemented with 10 mM HEPES, 0.05 mM 2-mercapto-
ethanol, 50 Ag/mL gentamicin, and 10% heat inactivated
fetal bovine serum, according to ATCC instructions. 3201
cells were contributed by Edward Hoover (Colorado State
University, Fort Collins, CO) and were grown in L15:RPMI
1640 (50:50), supplemented with 20% FBS, 2 mM
glutamine, and 50 Ag/mL gentamicin. All cell lines were
maintained at 37 8C and 5% CO2. Feline PBMCs were
isolated from blood as described in Barr et al. (1995), and
cultured as above in RPMI 1640 as described for the T-cell
lines.
FIV-Oma was isolated from a Pallas’ cat and expanded in
domestic feline PBMCs. Aliquots of cell culture super-
natants were frozen at 80 8C. Reverse-transcriptase
activity was used as an indicator of virus replication.
pOma3: CrFK cells were transfected with pOma3 using
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instructions. The first round of virus was collected on day 3
post-transfection and used to infect either MYA-1 or CrFK
cells. Supernatants were collected at peak virus levels as
determined by reverse-transcriptase activity. pPPR and FIV-
14: CrFK cells were transfected using lipofectamine
(Invitrogen) according to the manufacturer’s instructions.
The first round of virus was collected on day 3 of culture
following transfection and used to infect MYA-1 cells.
Reverse-transcriptase assay
Supernatants (10 Al/reaction) were incubated at 37 8C for
2 h in 20 mM KCl, 50 mM Tris, pH 7.8, 20 mM MgCl2,
poly(rA)/oligo(dT), and [3H] thymidine triphosphate. The
reaction mixture was spotted on strips of DEAE paper,
washed several times with 2% Na2HPO4, followed by
washes in milli-Q water and 95% ethanol. The strips were
dried and 3H-thymidine incorporation determined in Eco-
scint scintillation fluid (National Diagnostics) (Barr et al.,
1995).
Cell-free infection
For tropism studies, cells were seeded at 5  105 cells/
mL in 6-mL aliquots of culture medium. Virus stocks from
CrFK supernates were added to cells at 1  106 RT cpm per
flask. Cells were maintained at 37 8C and 5% CO2, with
medium replacement every 2–3 days. Medium samples were
collected every 2–3 days for determination of RT activity.
For kinetic and apoptosis studies, cells were seeded at 1 
106 cells/ml in 30-mL aliquots of culture medium. MYA-1
cells were infected with a single virus supernatant stock of
either pPPR or pOma-3 at levels of 1  106 (=log0), 1  107
(=log1), and 1  108 cpm (=log2)/30 mL. Medium and cell
samples were collected daily for determination of apoptosis
(by flow cytometry and by microscopy), immunocytochem-
istry, RT activity, cellular DNA, and media levels of viral
RNA.
Apoptosis
Samples of 1  106 cells were collected from each flask.
Cells were stained with 10 Al Hoechst 33342 (100 Ag/mL,
Sigma) at room temperature in the dark for 15 min. After
centrifugation (5 min at 1000  g), cells were suspended in
200 AL Annexin V binding buffer (10 mM HEPES/NaOH,
140 mM NaCl, and 2.5 mM CaCl2, pH 7.4). 5 AL Annexin-
V FITC (Biosource International) was added to each tube,
and the cells were incubated for 15 min at room temperature
in the dark. 10 AL propidium iodide (100 Ag/mL, Sigma)
was added to each tube to identify necrotic cells. Cells were
either attached to slides by cytospin (10 min, 1000 RPM)
and fixed with 3% paraformaldehyde for evaluation by
microscopy, or diluted to 1 ml with PBS for evaluation by
flow cytometry.Immunocytochemistry
Samples of 1  106 cells were collected from each
flask. Cells were stained with 10 AL Hoechst 33342 (100
Ag/mL, Sigma), as above. After centrifugation for 5 min,
1000  g, cells were suspended in 200 AL of a buffer
containing 10 mM HEPES/NaOH, 140 mM NaCl, and 2.5
mM CaCl2, pH 7.4. 10 AL propidium iodide (100 Ag/mL,
Sigma) was added to each tube to distinguish necrotic cells.
Cells were then cytospun onto slides (10 min at 1000
RPM) and fixed with 3% paraformaldehyde for 15 min at
room temperature. Slides were treated with 50 mM NH4Cl/
PBS to reduce quenching, and cells were permeabilized
with 0.1% Triton X-100 for 2 min. After blocking with
10% goat serum for 10 min, cells were treated with mouse
anti-FIV p24 IgG (Biodesign International) for 30 min,
followed by treatment with goat anti-mouse IgG conju-
gated with Alexa-Flour 488 (Molecular Probes), also for 30
min. Coverslips were mounted with Vecta-shield (Vector
Laboratories). All operations were carried out at room
temperature.
Isolation of DNA from cells
1-mL aliquots of cells (1–2 106 cells/mL)were collected
daily from each flask and centrifuged at 1000  g, 5 min.
Pellets were stored in 1.5 mL microcentrifuge tubes at
80 8C. Cells were resuspended in 200 AL PBS and DNA
was isolated using the Qiagen Mini Blood Kit according to
the manufacturer’s vacuum protocol. DNAs were applied
to columns using a QiaVac 24.
Isolation of RNA from cell culture medium
Cell-free supernatants (1 mL) were stored frozen at
80 8C. Cell-culture supernatant RNA was isolated using a
Qiagen Viral RNA mini kit according to the manufacturer’s
instructions.
Quantitative PCR
Primers for both pOma3 and pPPR were chosen within
the gag-pol region of the viral genome to be able to detect
full-length (late portion of the viral life cycle) transcripts as
opposed to env or other subgenomic transcripts. The
Universal PCR Master Mix from Applied Biosystems was
used for all amplifications. Primers for pPPR were selected
from the polymerase gene. The specific primers used were
forward 5V-CAA ATG TTG GCA AGG TGG-3Vat 50 nM and
reverse 5V-TCT GGC CTC TTT TCT AAT GAT G-3Vat 300
nM, and probe 5V- FAM-TTC GGG AAA CTG GAA GGC
GG-TAMRA -3Vat 100 nM. Primers used to amplify pOma3
sequences were selected from the gag gene. The specific
primers used for pOma3 gag were forward 5V-GGA GAG
CTG CTG CCC CTA T -3Vat 300 nM and reverse 5V- GAG
GAG CCG AAG GCT GTATTA A -3Vat 300 nM, and probe
C.A. Sutton et al. / Virology 332 (2005) 519–528 5275VFAM-ATT TCA AAC AGC AGT ATC AAC AAC TCA
GAA TCA GC-TAMRA-3Vat 50 nM. Primers and probes
were purchased from Integrated DNA Technologies. PCR
amplification was performed in 25 AL reaction volumes,
with samples run in triplicate. Serial log dilutions of
subclones containing target gene sequences (restriction
fragments cloned into pGEM-7Zf(+) (Promega) were used
to develop standard curves. Plasmid standards were diluted
in TE. Standard Taqman amplification conditions were used
on an ABI 7700 (Applied Biosystems).
qRT-PCR
TaqManR One-Step RT-PCR Master Mix Reagents Kit
from Applied Biosystems was used according to manufac-
turer’s instructions on all samples. Primers and probes are
described above and were used at the same concentrations
as described for DNA amplification. Reverse transcription
and amplification conditions were as described in the kit
manual. RNA copy numbers were determined by compar-
ison with standard curves of in vitro generated transcripts
(Maxiscript -T7 kit, Ambion) from the subclones described
above. Samples were run in triplicate.
Sequence data
The sequence of the pOma3 proviral clone has been
deposited in GenBank, accession number AY713445. The
clone was propagated in pBluescript (Stratagene) as a NotI
(5V LTR)–SalI (3VLTR) fragment. The pPPR proviral
sequence is GenBank accession M36968.Acknowledgment
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